Vivani Medical Mergers and Acquisitions Presentation Deck
Vivani Medical, Inc.
Pro-Forma P&L Statement
($ in 000s)
For the six months ended June 30, 2022:
Net sales
Cost of sales
Gross profit
Total operating expenses
Loss from operations
Loss per share on a pro forma basis
For the year ended December 31, 2021:
Net sales
Gross profit
Total operating expenses
Loss from operations
Loss per share on a pro forma basis
Historical
Second Sight
5,345
(5.345)
130
9,063
(8.933)
$
NPM
7,995
(7,995)
13,323
(13,323)
Pro forma
adjustments
(1,615)
1.615
2,154
(2.154)
$
$
Pro forma
combined
11,725
(11,725)
(0.23)
130
24,540
(24,410)
(0.55)
(The unaudited pro forma condensed combined financial information was derived from, and should be read in conjunction with,
the Exhibit 99.3 included in Form 8-K filed with the SEC on September 2, 2022)
24View entire presentation